
|Videos|April 11, 2020
Weekly Webinar Series Part 2: Managing Lung Cancer Patients Through the COVID-19 Pandemic
Advertisement
Led by Nathan Pennell, MD, PhD; Stephen Liu, MD; Charu Aggarwal, MD, MPH; and H. Jack West, MD, these top leaders in the lung cancer space shared insights on the novel corona-virus disease 2019 (COVID-19) and how the pandemic is poised to have a significant impact on lung cancer treatment and the healthcare system.
Topics Include:
- Knowing the best practices before patients come to clinic
- How molecular testing is being impacted by COVID-19
- How is clinical trial enrollment being affected in the wake of the pandemic
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5






































